PL BioScience GmbH is a Germany-based life science company committed to delivering safe and animal component-free cell expansion tools. PL BioScience was founded in 2015 as an RWTH Aachen University spin-off. Since then, they have been exploiting the broad potential of human platelets – the basis of their cell culture supplement Human Platelet Lysate (HPL). The company’s mission is to enhance the advances in cellular research and therapy with one forward-looking Technology: ELAREM™

The ELAREM™ Platform features a portfolio of use-case tailored cell culture supplements based on Human Platelet Lysate. The high growth factor content combined with animal-free origin not only supports optimal cell growth, but also enables its use in various applications. Compared to traditional Fetal Bovine Serum (FBS) cell culture supplement, HPL comes with the benefits of:

• Minimal risk of contamination from animal-derived bacteria and viruses
• Lot-to-lot consistency from large batch manufacturing
• Steady and reliable supply of GMP compliant material
• Free of animal welfare ethical concerns

From academic research, to pre-clinical research, and cellular therapy, the high quality, GMP compliant standards of ELAREM™ ensures seamless transitions of regenerative medicine breakthroughs – from the lab to patients in need.